- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immune monitoring and treatment in immune-mediated inflammatory diseases ; volume:13 ; number:1 ; day:7 ; month:6 ; year:2022 ; pages:1 ; date:12.2022
Nature Communications ; 13, Heft 1 (7.6.2022), 1, 12.2022
- Creator
-
Wijk, Femke van
Bruin, Marjolein de
Leavis, Helen
Nierkens, Stefan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-30891-7
- URN
-
urn:nbn:de:101:1-2022080710375959171447
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wijk, Femke van
- Bruin, Marjolein de
- Leavis, Helen
- Nierkens, Stefan
- SpringerLink (Online service)
Other Objects (12)
Cancer risk in immune-mediated inflammatory diseases (IMID)
Urine metabolome profiling of immune-mediated inflammatory diseases
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases
Recent advances of exosomes in immune-mediated eye diseases
Cancer risk in immune-mediated inflammatory diseases (IMID)
Urine metabolome profiling of immune-mediated inflammatory diseases
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases
Recent advances of exosomes in immune-mediated eye diseases
Cancer risk in immune-mediated inflammatory diseases (IMID)
Urine metabolome profiling of immune-mediated inflammatory diseases
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases